Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Therapeutics

49.95
+0.43000.87%
Post-market: 49.950.00000.00%16:18 EDT
Volume:861.91K
Turnover:43.07M
Market Cap:3.94B
PE:-10.57
High:50.43
Open:49.88
Low:49.03
Close:49.52
Loading ...
Jun 04, 2020

Major Issues Report

8-K - Current report
May 08, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
May 06, 2020

Major Issues Report

Current report, items 1.01, 3.02, 7.01, and 9.01
Apr 30, 2020

Major Issues Report

8-K - Current report
Apr 30, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Apr 30, 2020

Major Issues Report

Current report, items 1.01, 3.02, and 9.01
Apr 17, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Mar 16, 2020

Major Issues Report

8-K - Current report
Mar 02, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2020

Major Issues Report

Current report, items 2.02, 7.01, and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 05, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 31, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Jan 17, 2020

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Jan 13, 2020

Major Issues Report

Current report, items 2.02, 7.01, and 9.01